Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCF Strategy in Advanced Anal Squamous Cell Carcinoma
NCT02402842Phase 2Completed
- Sponsor
- CHU de Besançon
- Start
- Sep 2014
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in anal canal squamous cell carcinoma (SCCA), sponsored by CHU de Besançon. Started Sep 2014; status: completed.
02
Drugs
docetaxel
03
Conditions
anal canal squamous cell carcinoma (SCCA)
Beyond the preview
Go deeper on NCT02402842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02402842.